GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.42X leverage
Performance
- Low
- ₹1,951
- High
- ₹2,028
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,028
- Previous Close₹2,018
- Volume597,304
- 50 DMA₹1,979.19
- 100 DMA₹1,938.18
- 200 DMA₹1,838.46
Investment Returns
- Over 1 Month + 0.8%
- Over 3 Month + 2.66%
- Over 6 Month -8.72%
- Over 1 Year + 29.13%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 55.7
- PEG Ratio
- 0.3
- Market Cap Cr
- 56,229
- P/B Ratio
- 5.9
- Average True Range
- 47.38
- EPS
- 89.11
- Dividend Yield
- 0.3
- MACD Signal
- 31.85
- RSI
- 51.43
- MFI
- 71.28
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,992.50
-25
(-1.24%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹2,021.96
- 50 Day
- ₹1,979.19
- 100 Day
- ₹1,938.18
- 200 Day
- ₹1,838.46
Resistance and Support
2001.83
- R3 2,088.87
- R2 2,054.63
- R1 2,036.07
- S1 1,983.27
- S2 1,949.03
- S3 1,930.47
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,992 As on 13 January, 2026 | 13:47
The Market Cap of Glenmark Pharmaceuticals is ₹56228.5 Cr As on 13 January, 2026 | 13:47
The P/E ratio of Glenmark Pharmaceuticals is 55.7 As on 13 January, 2026 | 13:47
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 13 January, 2026 | 13:47
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.